Key Metrics
Company Snapshot
Precision Neuroscience is a Biotech company, based in New York, New York, USA, founded 2021. Latest valuation ~$1B (As of Sep 24, 2026, GlobeNewswire). Total funding $430M (As of Sep 24, 2026).
Recent changes
- Sep 25, 2026Sep 25, 2026Precision Neuroscience Raises $250M For Brain Implants Pulse story
- Sep 24, 2026Sep 24, 2026Raised $250M Series D at a ~$1B valuation GlobeNewswire
- Sep 24, 2026Sep 24, 2026First reported valuation: ~$1B GlobeNewswire
- Sep 24, 2026Sep 24, 2026First reported total funding: $430M GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: Duquesne Family Office GlobeNewswire
Earlier changes (11)
- Sep 24, 2026Sep 24, 2026New investor: Ackman Oxman Institute GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: Pershing Square GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: Invus GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: Hitachi Ventures GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: ARK Invest GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: Mubadala Capital GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: B Capital GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: Mirae Asset GlobeNewswire
- Sep 24, 2026Sep 24, 2026New investor: Korea Investment Partners GlobeNewswire
- Sep 24, 2026Sep 24, 2026Precision Neuroscience Hits $1B Valuation On $250M Raise Pulse story
- Sep 24, 2026Sep 24, 2026Ackman Co-Leads Precision Neuroscience's $250M Round Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Sep 24, 2026 | Series D | $250M | ~$1B | Pershing SquareLeadunverifiedAckman Oxman InstituteLeadunverifiedDuquesne Family OfficeunverifiedB CapitalARK InvestInvusMubadala CapitalMirae AssetKorea Investment PartnersHitachi VenturesJSL Health Capital | GlobeNewswire |
Investors
Latest Pulse
- Sep 30, 2026Tiny Health Raises $33M Series B For MicrobiomeAustin-based Tiny Health raised a $33 million Series B led by B Capital, bringing its total funding to $46 million, to advance clinical research, expand education for healthcare practitioners and scale Powered by Tiny, its B2B platform.→
- Sep 28, 2026Health AI Raised $655M+ In Just Three DealsOpenEvidence, Precision Neuroscience and Rightway alone pulled in more than $655 million in late-September rounds, underscoring how much AI capital is now flowing into healthcare specifically.→
- Sep 25, 2026OpenEvidence Raises $250M Led By Andreessen HorowitzOpenEvidence, the Miami-based clinical search platform for physicians, raised a new $250 million round led by hospital systems and Andreessen Horowitz.→
- Sep 25, 2026Precision Neuroscience Raises $250M For Brain ImplantsPrecision Neuroscience raised $250 million to advance its brain-computer interface technology, backed by Bill Ackman's Pershing Square and the Ackman Oxman Institute.→
- Sep 24, 2026AI Agent Security Just Had A $1.15B WeekIsland, Cyera and BigHat Biosciences alone raised more than $1.1 billion this week to build the layer that governs what AI agents can access and do -- evidence the market has already priced in the exact failure mode this issue's lead story just demonstrated.→
- Sep 24, 2026Precision Neuroscience Hits $1B Valuation On $250M RaisePrecision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square and his new Ackman Oxman Institute, valuing the brain-computer interface company at just over $1 billion.→
- Sep 24, 2026Ackman Co-Leads Precision Neuroscience's $250M RoundPrecision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square, valuing the brain-computer interface company at just over $1 billion as it scales past 100 patient procedures.→
Coverage Timeline
newest first- Sep 28, 2026FUNDINGHealth AI Raised $655M+ In Just Three Deals$655M+ combined→
- Sep 25, 2026FUNDINGPrecision Neuroscience Raises $250M For Brain Implants$250M Series D→
- Sep 24, 2026FUNDINGPrecision Neuroscience Hits $1B Valuation On $250M Raise$250M Series D→
- Sep 24, 2026FUNDINGAckman Co-Leads Precision Neuroscience's $250M Round$250M Series D→
All Coverage
FUNDING$655M+ combined
Health AI Raised $655M+ In Just Three Deals
OpenEvidence, Precision Neuroscience and Rightway alone pulled in more than $655 million in late-September rounds, underscoring how much AI capital is now flowing into healthcare specifically.
BY THE NUMBERS
Precision Neuroscience Raises $250M For Brain Implants
FUNDING$250M Series D
Precision Neuroscience Raises $250M For Brain Implants
Precision Neuroscience raised $250 million to advance its brain-computer interface technology, backed by Bill Ackman's Pershing Square and the Ackman Oxman Institute.
DEEP DIVE
Precision Neuroscience Hits $1B Valuation On $250M Raise
FUNDING$250M Series D
Precision Neuroscience Hits $1B Valuation On $250M Raise
Precision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square and his new Ackman Oxman Institute, valuing the brain-computer interface company at just over $1 billion.
DEEP DIVE
Ackman Co-Leads Precision Neuroscience's $250M Round
FUNDING$250M Series D
Ackman Co-Leads Precision Neuroscience's $250M Round
Precision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square, valuing the brain-computer interface company at just over $1 billion as it scales past 100 patient procedures.
DEEP DIVE
Related Companies
Precision Neuroscience FAQ
What is Precision Neuroscience's valuation?
Precision Neuroscience's valuation is ~$1B (As of Sep 24, 2026, GlobeNewswire).
How much has Precision Neuroscience raised?
Precision Neuroscience has raised $430M in total funding (As of Sep 24, 2026, GlobeNewswire).
Who are Precision Neuroscience's investors?
Precision Neuroscience's investors include Ackman Oxman Institute, Pershing Square, ARK Invest, B Capital, Duquesne Family Office, and 7 more (As of Sep 24, 2026).
Sources & methodologyshow
Where these figures come from
- GlobeNewswireprimary source3 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.